GRAL Deadline Reminder: GRAIL, Inc. Securities Fraud Class Action Over Alleged Misrepresentations is Ongoing - August 4 Court Deadline For Investors is Approaching
Bleichmar Fonti & Auld LLP issued a reminder regarding the lead plaintiff deadline for a securities fraud class action against GRAIL, Inc. connected to its NHS-Galleri cancer trial. The suit alleges GRAIL made misrepresentations about the trial design, preceding a 50.55% stock drop after the company announced the trial failed to meet its primary endpoint. Investors have until August 4, 2026 to move for lead plaintiff appointment in the U.S.
Key figures
- Stock drop percent
- 50.55%
- Lawsuit case number
- 26-cv-05428
- Lead plaintiff deadline
- August 4, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.